Internal Medicine, Pulmonary Disease · Peoria, AZ
NPI
1710069885
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
13634 N 93rd Ave Ste 100
Peoria, AZ, 85381
Phone (623) 933-0301
Groups this clinician bills Medicare through
Medicare paid, 2024
$198K
2,873 services
Medicare patients, 2024
575
Average age 77
Drug cost, 2024
$1.0M
3,196 prescriptions
Company payments, 2025
$15K
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Thomas W Pollard was code 99214 (office e&m - established), 981 times for 365 patients. In total Thomas W Pollard billed 2,873 services in 18 codes, and Medicare paid $198K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-09-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 981 | 365 | $93.68 | $92K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 708 | 295 | $12.99 | $9,195 |
| 99233 Hospital E&M - Subsequent | Facility | 391 | 146 | $92.16 | $36K |
| 99232 Hospital E&M - Subsequent | Facility | 293 | 122 | $62.53 | $18K |
| 99223 Hospital E&M - Initial | Facility | 144 | 135 | $131.17 | $19K |
| 99204 Office E&M - New | Office | 114 | 114 | $116.42 | $13K |
| 94729 Pulmonary Function Testing | Office | 74 | 73 | $44.70 | $3,307 |
| 94726 Pulmonary Function Testing | Office | 73 | 72 | $43.54 | $3,179 |
| 94060 Pulmonary Function Testing | Office | 66 | 65 | $30.26 | $1,997 |
By year: 2022 $148K for 1,843 services; 2023 $154K for 1,800 services; 2024 $198K for 2,873 services.
Medicare prescription drug claims, 2024
In 2024, the drug Thomas W Pollard prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 562 prescriptions and refills. In total Thomas W Pollard wrote 3,196 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 562 | 748 | 133 | $470K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 489 | 637 | 162 | $13K |
| Prednisone Generic | 387 | 413 | 162 | $1,069 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 176 | 236 | 40 | $112K |
| Spiriva Respimat Tiotropium Bromide | 110 | 133 | 29 | $69K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 97 | 133 | 31 | $80K |
| Cefdinir Generic | 82 | 82 | 50 | $1,552 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 80 | 152 | 28 | $20K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 79 | 79 | 40 | $386 |
| Methylprednisolone Generic | 76 | 76 | 36 | $553 |
| Montelukast Sodium Generic | 67 | 158 | 23 | $811 |
| Ipratropium Bromide Generic | 62 | 81 | 30 | $1,342 |
| Wixela Inhub Fluticasone Propion/Salmeterol | 60 | 92 | 24 | $11K |
| Symbicort Budesonide/Formoterol Fumarate | 52 | 68 | Under 11 | $16K |
| Fluconazole Generic | 51 | 64 | 21 | $4,125 |
Brand drugs: 1,429 claims; generic drugs: 1,767 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Thomas W Pollard $15K ($15K in general payments such as food, travel and fees) from 22 companies. The largest payer was Viatris Specialty LLC with $12K.
| Company | Payments | Amount |
|---|---|---|
| Viatris Specialty LLC | 18 | $12K |
| Genzyme Corporation SNY | 18 | $650 |
| AstraZeneca Pharmaceuticals LP AZN | 14 | $578 |
| Regeneron Healthcare Solutions, Inc. REGN | 11 | $349 |
| Merck Sharp & Dohme LLC MRK | 12 | $300 |
| Verona Pharma, Inc. VRNA | 9 | $284 |
| Insmed, Inc. INSM | 14 | $220 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $217 |
| GlaxoSmithKline, LLC. GSK | 13 | $204 |
| Electromed, Inc. ELMD | 15 | $180 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.